<DOC>
	<DOCNO>NCT00346866</DOCNO>
	<brief_summary>The purpose study evaluate efficacy anecortave acetate depot suspension ( 30 mg 15 mg ) plus PDT versus PDT alone respect maintenance visual acuity patient wet AMD .</brief_summary>
	<brief_title>Anecortave Acetate Versus Placebo AMD Patients Following PDT</brief_title>
	<detailed_description />
	<mesh_term>Anecortave</mesh_term>
	<criteria>AMD disease Age</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2008</verification_date>
</DOC>